We are live on ! Find out more
OAM

Ostrum Asset Management Portfolio holdings

AUM $1.78B
1-Year Est. Return 27.8%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+27.8%
3 Year Est. Return
+75.23%
5 Year Est. Return
10 Year Est. Return
AUM
$1.19B
AUM Growth
+$45.2M
Cap. Flow
-$7.82M
Cap. Flow %
-0.66%
Top 10 Hldgs %
13.85%
Holding
680
New
9
Increased
444
Reduced
167
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 21.56%
2 Healthcare 18.99%
3 Financials 12.17%
4 Consumer Staples 10.12%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLD icon
76
Prologis
PLD
$136B
$4.1M 0.34%
33,470
-1,356
-4% -$167K
DBX icon
77
Dropbox
DBX
$7.78B
$4.1M 0.34%
153,727
-1,058
-0.7% -$24.1K
CBRE icon
78
CBRE Group
CBRE
$43.3B
$4.1M 0.34%
50,777
-2,137
-4% -$160K
XOM icon
79
ExxonMobil
XOM
$650B
$4.09M 0.34%
38,123
-420
-1% -$45.8K
PG icon
80
Procter & Gamble
PG
$340B
$3.99M 0.33%
26,288
+48
+0.2% +$7.24K
COST icon
81
Costco
COST
$432B
$3.95M 0.33%
7,331
-68
-0.9% -$34.4K
BRK.B icon
82
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.95M 0.33%
11,570
-224
-2% -$73.1K
BAH icon
83
Booz Allen Hamilton
BAH
$8.44B
$3.92M 0.33%
35,160
+31
+0.1% +$3.06K
LKQ icon
84
LKQ Corp
LKQ
$6.72B
$3.82M 0.32%
65,628
-3,123
-5% -$174K
TMUS icon
85
T-Mobile US
TMUS
$195B
$3.79M 0.32%
27,321
-261
-0.9% -$36.6K
BMRN icon
86
BioMarin Pharmaceuticals
BMRN
$11.9B
$3.75M 0.31%
43,310
-250
-0.6% -$23.5K
REGN icon
87
Regeneron Pharmaceuticals
REGN
$72.9B
$3.75M 0.31%
5,213
-72
-1% -$55.5K
SPGI icon
88
S&P Global
SPGI
$124B
$3.73M 0.31%
9,315
-366
-4% -$134K
T icon
89
AT&T
T
$164B
$3.73M 0.31%
233,729
-2,866
-1% -$48.8K
CVS icon
90
CVS Health
CVS
$135B
$3.72M 0.31%
53,842
-257
-0.5% -$18.3K
IPG
91
DELISTED
Interpublic Group of Companies
IPG
$3.72M 0.31%
96,308
-5,650
-6% -$213K
CMCSA icon
92
Comcast
CMCSA
$87.3B
$3.69M 0.31%
88,765
-1,706
-2% -$67.8K
ORLY icon
93
O'Reilly Automotive
ORLY
$75.1B
$3.68M 0.31%
57,780
+60
+0.1% +$3.66K
GPC icon
94
Genuine Parts
GPC
$17.9B
$3.66M 0.31%
21,629
-777
-3% -$127K
LDOS icon
95
Leidos
LDOS
$14.4B
$3.65M 0.31%
41,283
+67
+0.2% +$5.71K
ABBV icon
96
AbbVie
ABBV
$465B
$3.6M 0.3%
26,745
-287
-1% -$42.1K
O icon
97
Realty Income
O
$61.1B
$3.56M 0.3%
59,577
-535
-0.9% -$32.7K
CDW icon
98
CDW
CDW
$18.9B
$3.56M 0.3%
19,405
-2,230
-10% -$390K
ZTS icon
99
Zoetis
ZTS
$32.7B
$3.53M 0.3%
20,472
-132
-0.6% -$22.8K
HAS icon
100
Hasbro
HAS
$13.5B
$3.51M 0.29%
54,125
-1,769
-3% -$103K

Similar funds

Ostrum Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Ostrum Asset Management held 680 positions worth $1.19B, up 3.9% from $1.15B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 2.5%. Ostrum Asset Management opened 9 new positions and exited 8, leaving the 680-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ostrum Asset Management's largest Q2 2023 buy was Coca-Cola Europacific Partners: 25,521 shares worth $1.64M.
  • Ostrum Asset Management added most to Descartes Systems in Q2 2023, an estimated $2.17M increase.
  • Ostrum Asset Management's biggest Q2 2023 reduction was Take-Two Interactive, cutting an estimated $3.66M.
  • Ostrum Asset Management fully exited Elanco Animal Health in Q2 2023, selling an estimated $770K.
  • Ostrum Asset Management's ten largest holdings make up 14% of its $1.19B portfolio in Q2 2023.
  • Ostrum Asset Management opened 9 new positions and closed 8 in Q2 2023.
  • Ostrum Asset Management's portfolio value rose 3.9% quarter-over-quarter to $1.19B.

Based on Ostrum Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.